Mepsevii Injection
Product Images NDC 69794-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mepsevii (NDC 69794-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ultragenyx Pharmaceutical Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Mepsevii 01)

FDA Label Image

Principal Display Panelndc 69794-001-01mepsevii(vestronldase Alfa-vjbk)injection10 mg/ 5 mL (2mg/ml)rx Only (Mepsevii 02)

This text provides information about the drug MEPSEVIT, which is an injection used for intravenous infusion. The container comes in a single-dose vial, which cannot be frozen or shaken, and must be discarded after use. Each mL of solution contains 5mg of vestronidase alfa-vjbk, sodium chloride 788 mg, and other ingredients. The drug is manufactured by Ultragenyx Pharmaceutical Inc. in Novato, CA. The text also mentions dosage and administration instructions, but further details are available in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.